BIOMAT Database Logo BIOMAT Database Logo

Clotting factor XIII and desmopressin improve hemostasis in uncontrolled bleeding. 2015

Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.

OBJECTIVE To investigate hemostatic effects of supplementary factor XIII and desmopressin (DDAVP) in resuscitation of uncontrolled bleeding. METHODS Fifty-four rabbits were randomized in nine groups: G1: Sham; G2: FXIII and normotensive resuscitation (NBP); G3: FXIII and permissive hypotension (PH) (MAP 60% baseline); G4: FXIII/DDAVP/NBP; G5: FXIII/DDAVP/PH; G6: NBP only; G7: FXIII no hemorrhage; G8: FXIII/DDAVP no hemorrhage; G9: PH only. Thromboelastometry and intra-abdominal blood loss were assessed. Scanning electron microscopy (EM) of the clots was performed. RESULTS Compared to Sham, only G8 (FXIII/DDAVP w/o hemorrhage) showed clotting time (CT) significantly lower (p<0.05). NBP alone (G6) resulted in significantly prolonged CT compared to G2, G3 and G5 (p<0.05). Similarly, median alpha angle was significantly larger in G3,4,5, and 9 compared to G6 (p<0.05). Area under the curve was significantly greater in G5 than G2. Intra-abdominal blood loss was lower in G5 and G9 compared to G2 and G6. FXIII/DDAVP and PH resulted in more robust fibrin mesh by EM. CONCLUSIONS Normotensive resuscitation provokes more bleeding and worsens coagulation compared to pH, that is partially reversed by factor XIII and desmopressin. FXIII and DDAVP can synergistically improve coagulation. Permissive hypotension reduces bleeding regardless of those agents.

UI MeSH Term Description Entries
D008297 Male Males
D008855 Microscopy, Electron, Scanning Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY. Scanning Electron Microscopy,Electron Scanning Microscopy,Electron Microscopies, Scanning,Electron Microscopy, Scanning,Electron Scanning Microscopies,Microscopies, Electron Scanning,Microscopies, Scanning Electron,Microscopy, Electron Scanning,Microscopy, Scanning Electron,Scanning Electron Microscopies,Scanning Microscopies, Electron,Scanning Microscopy, Electron
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012151 Resuscitation The restoration to life or consciousness of one apparently dead. (Dorland, 27th ed) Resuscitations
D003894 Deamino Arginine Vasopressin A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. Desmopressin,Vasopressin, Deamino Arginine,1-Deamino-8-D-arginine Vasopressin,1-Desamino-8-arginine Vasopressin,Adiuretin,Adiuretin SD,Apo-Desmopressin,DDAVP,Desmogalen,Desmopressin Acetate,Desmopressin Monoacetate,Desmopressin Monoacetate, Trihydrate,Desmopressine Ferring,Desmospray,Desmotabs,Minirin,Minurin,Nocutil,Octim,Octostim,Acetate, Desmopressin,Arginine Vasopressin, Deamino,Ferring, Desmopressine,Monoacetate, Desmopressin,Monoacetate, Trihydrate Desmopressin,Trihydrate Desmopressin Monoacetate,Vasopressin, 1-Deamino-8-D-arginine,Vasopressin, 1-Desamino-8-arginine
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics

Related Publications

Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
[Clotting factor XIII].
January 1981, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
Congenital deficiency of clotting factor XIII.
June 1974, The Journal of the American Osteopathic Association,
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
Factor XIII and surgical bleeding.
March 2022, Minerva anestesiologica,
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
Unlucky bleeding: factor XIII.
March 2022, Minerva anestesiologica,
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
Desmopressin and hemostasis.
April 1993, Regulatory peptides,
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia.
January 2021, Clinical pharmacokinetics,
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
Desmopressin and surgical hemostasis.
April 1990, The New England journal of medicine,
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
Desmopressin (DDAVP) and hemostasis.
October 1994, Annals of hematology,
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
[Speeding wound healing by blood clotting factor XIII].
October 1971, Arzneimittel-Forschung,
Paulo Roberto Lima Carreiro, and Joao Baptista de Rezende-Neto, and Thiago de Assis Lisboa, and Daniel Dias Ribeiro, and Elizabeth Ribeiro da Silva Camargos, and Marcus Vinicius de Melo Andrade, and Sandro Baletotti Rizoli, and Jose Renan da Cunha Melo
[Importance of factor XIII for hemostasis and wound healing].
March 1972, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!